Valuation: Terumo Corporation

Market Cap 3,942B 24.77B 21.4B 20.11B 18.29B 34.38B 2,369B 34.95B 236B 92.11B 1,186B 93.01B 90.99B P/E 2027 *
21.1x
P/E 2028 * 20.8x
Enterprise Value 4,008B 25.19B 21.75B 20.44B 18.59B 34.95B 2,408B 35.53B 240B 93.65B 1,206B 94.56B 92.51B EV / Sales 2027 *
3.2x
EV / Sales 2028 * 2.94x
Free-Float
97.07%
Yield 2027 *
1.37%
Yield 2028 * 1.51%
1 day+1.98%
1 week+15.59%
Current month+15.00%
1 month+20.74%
3 months+37.05%
6 months+32.93%
Current year+17.73%
1 week 2,455.5
Extreme 2455.5
2,676.5
1 month 2,133
Extreme 2133
2,676.5
Current year 1,900
Extreme 1900
2,676.5
1 year 1,900
Extreme 1900
2,813.5
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%+15.59%-4.40%+22.62% 24.25B
+0.08%+3.34%-13.82%+5.00% 193B
+1.28%+5.23%-0.28%+10.29% 116B
+0.83%-2.77%+5.67%+66.06% 59.16B
+0.32%+4.59%+34.37%+62.62% 55.75B
+0.59%+3.59%-6.04%-35.18% 49.57B
-1.99%+5.90%+12.24%-22.47% 34.52B
+0.17%+1.12% - - 31.22B
+0.73%-1.63%+41.47%-12.90% 24.36B
-1.14%-1.72%-5.18%+1.85% 23.02B
Average +0.28%+3.85%+7.11%+10.88% 61.03B
Weighted average by Cap. +0.38%+3.46%+0.80%+12.63%

Financials

2027 *2028 *
Net sales 1,252B 7.87B 6.8B 6.39B 5.81B 10.92B 752B 11.1B 74.82B 29.25B 377B 29.54B 28.9B 1,332B 8.37B 7.23B 6.79B 6.18B 11.62B 800B 11.81B 79.6B 31.12B 401B 31.43B 30.75B
Net income 184B 1.16B 1B 941M 856M 1.61B 111B 1.64B 11.02B 4.31B 55.51B 4.35B 4.26B 190B 1.19B 1.03B 968M 880M 1.65B 114B 1.68B 11.34B 4.43B 57.1B 4.48B 4.38B
Net Debt 65.54B 412M 356M 334M 304M 572M 39.39B 581M 3.92B 1.53B 19.72B 1.55B 1.51B -24.64B -155M -134M -126M -114M -215M -14.81B -218M -1.47B -576M -7.41B -581M -569M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
14/08/26 ¥2,672.50 +1.98% 5,922,200
13/08/26 ¥2,620.50 +0.85% 5,893,400
12/08/26 ¥2,598.50 +0.89% 6,704,400
10/08/26 ¥2,575.50 +8.53% 8,398,500
07/08/26 ¥2,373.00 +2.64% 4,340,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,672.50JPY
Average target price
3,083.08JPY
Spread / Average Target
+15.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock